FEB 11, 2021 8:00 AM PST

Smartwatches Keep a Close Eye on Parkinson's Patients

WRITTEN BY: Tara Fernandez

Individuals with Parkinson’s disease experience a slow, progressive worsening of symptoms. What can begin as barely perceptible tremors can end up becoming a complete inability to move around. 

Though there is still no cure for the disease, clinical interventions can put the brakes on disease progression, especially when initiated early. Fine-tuning the treatment is also an important part of managing the condition, for which patients need to check in with doctors every few months. However, it’s difficult for patients to recount the details and specifics around the symptoms to track progression. Was it more difficult to do chores around the house? How bad were the tremors?

According to a recent pilot study, technology may be able to bridge this gap in monitoring patients. Smartwatches typically have in-built hardware such as gyroscopes and accelerometers that can detect and measure subtle motor movements. Now, together with a new app developed by Apple Inc. called the Motor Fluctuations Monitor, wearable trackers could help physicians keep tabs on how their patients are faring.

Engineers and researchers teamed up in a study that used the Apple smartwatch and app to follow 225 patients with Parkinson’s over the course of half a year. The findings were published in Science Translational Medicine.

The team discovered that this innovative approach to patient tracking captured very subtle changes in symptoms that were missed even by patients’ families and caregivers. This information provided critical missing pieces for doctors designing treatment strategies that closely align with the disease's progression.

“The smartwatch-based system could identify changes in symptoms resulting from better adherence to medication or deep brain stimulation treatment, as well as subclinical symptoms, suggesting a need for alternative treatment or medication titration,” wrote the authors.

Around 60,000 Americans are diagnosed with Parkinson’s every year. The next steps have not yet been decided. Still, before becoming a routine part of clinical practice, the monitoring system will first need to undergo clinical trials before securing regulatory approval.

 

 

Source: Science Translational Medicine.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
APR 19, 2021
Genetics & Genomics
Better Disease Risk Predictions May Come From Ancestry Data, Not Race
APR 19, 2021
Better Disease Risk Predictions May Come From Ancestry Data, Not Race
Researchers have suggested that it's time for medicine to move away from demographic labels that are too narrow to captu ...
MAY 31, 2021
Clinical & Molecular DX
Researchers Create the First Saliva Wiki
MAY 31, 2021
Researchers Create the First Saliva Wiki
A new digital platform, developed by researchers at the University at Buffalo, is answering the question: what’s o ...
JUN 17, 2021
Clinical & Molecular DX
A RADICA Approach to Viral Diagnostics
JUN 17, 2021
A RADICA Approach to Viral Diagnostics
  The COVID-19 pandemic has spurred a wave of new technologies for rapid viral diagnostics, given just how critical ...
AUG 03, 2021
Drug Discovery & Development
A pediatric-friendly drug to combat snail fever
AUG 03, 2021
A pediatric-friendly drug to combat snail fever
           Schistosomiasis, also known as Bilharzia or snail fever, is a disease  ...
AUG 12, 2021
Clinical & Molecular DX
Computers Pick Up the 'Sound' of Thyroid Cancer
AUG 12, 2021
Computers Pick Up the 'Sound' of Thyroid Cancer
Researchers have developed a new technology for the non-invasive diagnosis of thyroid cancer that combines photoacoustic ...
SEP 20, 2021
Cancer
An Established Ovarian Cancer Antigen Presents a Promising Therapeutic Target
SEP 20, 2021
An Established Ovarian Cancer Antigen Presents a Promising Therapeutic Target
For the past several decades, cancer antigen 125 (CA 125), a protein located on the surface of ovarian cancer cells, has ...
Loading Comments...